Prospective, Noninterventional Study of Nivolumab in Real-world Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Chemotherapy (ENLARGE-Lung).

Sebastian M, Gröschel A, Gütz S, Schulz H, Müller-Huesmann H, Liersch R, von der Heyde E, Wiegand J, Ukena D, Bargon J, Schütte W, Riera-Knorrenschild J, Fischer JR, Griesinger F, Allan V, Waldenberger D, Schumann C

Open source

DOI: 10.1097/cji.0000000000000397
Published: 2022 Feb-Mar 01
Container: Journal of immunotherapy (Hagerstown, Md. : 1997)
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/cji.0000000000000397,
  title = {Prospective, Noninterventional Study of Nivolumab in Real-world Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Chemotherapy (ENLARGE-Lung).},
  author = {Sebastian M and Gröschel A and Gütz S and Schulz H and Müller-Huesmann H and Liersch R and von der Heyde E and Wiegand J and Ukena D and Bargon J and Schütte W and Riera-Knorrenschild J and Fischer JR and Griesinger F and Allan V and Waldenberger D and Schumann C},
  year = {2022},
  journal = {Journal of immunotherapy (Hagerstown, Md. : 1997)},
  doi = {10.1097/cji.0000000000000397},
  url = {https://doi.org/10.1097/cji.0000000000000397}
}

RIS

TY  - JOUR
TI  - Prospective, Noninterventional Study of Nivolumab in Real-world Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Chemotherapy (ENLARGE-Lung).
AU  - Sebastian M
AU  - Gröschel A
AU  - Gütz S
AU  - Schulz H
AU  - Müller-Huesmann H
AU  - Liersch R
AU  - von der Heyde E
AU  - Wiegand J
AU  - Ukena D
AU  - Bargon J
AU  - Schütte W
AU  - Riera-Knorrenschild J
AU  - Fischer JR
AU  - Griesinger F
AU  - Allan V
AU  - Waldenberger D
AU  - Schumann C
PY  - 2022
JO  - Journal of immunotherapy (Hagerstown, Md. : 1997)
DO  - 10.1097/cji.0000000000000397
UR  - https://doi.org/10.1097/cji.0000000000000397
ER  -

APA

M, S., A, G., S, G., H, S., H, M., R, L., E, V. D. H., J, W., D, U., J, B., W, S., J, R., JR, F., F, G., V, A., D, W., & C, S. (2022). Prospective, Noninterventional Study of Nivolumab in Real-world Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Chemotherapy (ENLARGE-Lung).. Journal of immunotherapy (Hagerstown, Md. : 1997). https://doi.org/10.1097/cji.0000000000000397

Source records

pubmed · retrieved 2026-09-27T09:43:38.261Z
europe-pmc · retrieved 2026-09-27T09:43:38.268Z